Long-term outcomes after deep vein thrombosis: Postphlebitic syndrome and quality of life
Cite this article as: Kahn, S.R., Solymoss, S., Lamping, D.L. et al. J GEN INTERN MED (2000) 15: 425. doi:10.1046/j.1525-1497.2000.06419.x Abstract
In this review, we critically assess the literature on the incidence of postphlebitic syndrome, risk factors for its occurrence, available therapeutic options, and its effects on quality of life. As well, we describe available tools to measure postphlebitic syndrome. Recent prospective studies indicate that postphlebitic syndrome, a chronic, potentially disabling condition characterized by leg swelling, pain, venous ectasia, and skin induration, is established by 1 year after deep vein thrombosis (DVT) in 17% to 50% of patients. The only prospectively identified risk factor for its occurrence is recurrent ipsilateral DVT. In the sole randomized study available, daily use of elastic compression stockings after proximal DVT reduced the incidence of postphlebitic syndrome by 50%. Treatment options for established postphlebitic syndrome are limited, but include compression stockings and intermittent compressive therapy with an extremity pump for severe cases. To date, quality of life after DVT has received little attention in the literature. The recent development of the VEINES-QOL questionnaire, a validated venous-disease-specific measure of quality of life, should encourage researchers to include quality of life as a routine outcome measure after DVT. There is no criterion standard for the diagnosis of postphlebitic syndrome, but a validated clinical scoring system does exist. More research on postphlebitic syndrome is needed to enable us to provide DVT patients with comprehensive, evidence-based information regarding their long-term prognosis, to help quantify the prevalence and health care burden of postphlebitic syndrome, and by identifying predictors of poor outcome, to develop new preventive strategies in patients at risk of developing this condition.
Key words postphlebitic syndrome deep vein thrombosis quality of life long-term outcome References
Anderson FA, Wheeler HB, Goldberg RJ et al. A population-based perspective on the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933–8.
Strandness DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250(10):1289–92.
Lindner DJ, Edwards JM, Phinney ES, et al. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. J Vasc Surg. 1986;4:436–42.
Villalta S, Bagatella P, Piccioli A, et al. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Hemostasis 1994;24(suppl 1):158a. Abstract.
Prandoni P, Lensing AWA, Cogo A. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7.
Brandjes DPM, Buller HR, Heijboer H. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–62.
Villalta S, Prandoni P, Cogo A, et al. The utility of non-invasive tests for detection of previous proximal-vein thrombosis. Thrombos Haemost. 1995;73:592–6.
Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med. 1995;155:1031–7.
Browse NL, Clemenson G, Lea Thomas M. Is the postphlebitic leg always postphlebitic? Relation between phlebographic appearances of deep-vein thrombosis and late sequelae. BMJ. 1980;281:1167–70.
Philbrick JT, Becker DM. Calf venous thrombosis: a wolf in sheep’s clothing? Arch Intern Med. 1988;148:2131–8.
Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49.
Kakkar VV, Lawrence D. Hemodynamic and clinical assessment after therapy for acute venous thrombosis: a prospective study. Am J Surg. 1985;54–63.
Trubestein G. Can thrombolytics prevent post-phlebitic syndrome and thromboembolic disease? Hemostasis. 1986;3(suppl 6):38–50.
Munkvad S, Jorgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol. 1996;134:296–8.
Wille-Jorgensen P, Jorgensen T, Andersen M, et al. Postphlebitic syndrome and general surgery: an epidemiological investigation. Angiology. 1991;397–403.
Hull R, Delmore F, Carter C, et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 1982;306:189–94.
Kearon C, Gent M, Hirsch J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340:901–7.
Biguzzi E, Mozzi E, Alatri A, Taioli E, Moia M, Mannicci PM. The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost. 1998;80:575–7.
Dalen JE, Hirsh J, eds. Fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1998;114(suppl).
Ridker PM, for the PREVENT Investigators. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) Trial. Vasc Med. 1998;3:67–73.
Gandhi DB, Palmar JR, Lewis B, Schraibman IG. Clinical comparison of elastic supports for venous diseases of the lower limb. Postgrad Med J. 1984;60:249–52.
Alguire PC, Mathes BM. Chronic venous insufficiency and venous ulceration. J Gen Intern Med. 1997;12:374–83.
Ginsberg JS, Brill-Edwards P, Kowalchuk G, Hirsh J. Intermittent compression units for the postphlebitic syndrome: a pilot study. Arch Intern Med. 1989;149:1651–2.
Ginsberg JS, Magier D, MacKinnon B, Gent M, Hirsh J. Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study. CMAJ. 1999;160:1303–6.
Lamping DL. Measuring health-related quality of life in venous disease: practical and scientific considerations. Angiology. 1997;48:51–57.
O’Donnell TF Jr, Browse NL, Burnand KG. The socioeconomic effects of an ileofemoral venous thrombosis. J Surg Res. 1977;22:483–8.
Garratt AM, Macdonald LM, Ruta DA, et al. Towards measurement of outcome for patients with varicose veins. Qual Health Care. 1993;2:5–10.
Franks PJ, Moffatt CJ, Connolly M, et al. Community leg ulcer clinics: effect on quality of life. Phlebology. 1994;9:83–6.
Hyland ME, Thomson B. Quality of life of leg ulcer patients: questionnaire and preliminary findings. J Wound Care. 1994;3:294–8.
Garratt AM, Ruta DA, Abdalla MI, et al. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440–4.
Price P, Harding K. Quality of life. Lancet. 1995;346:445. Letter.
Lindholm C, Bjellerup M, Christensen OB, et al. Quality of life in chronic leg ulcer patients. Acta Dermato-Venereol. 1993;73:440–3.
Franks PJ, Wright DDI, Fletcher AE, et al. A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg. 1992;158:149–55.
Launois R, Reboul-Marty J, Henry B. Construction et validation d’un indicateur spécifique de qualité de vie: le cas de l’insuffisance veineuse chronique des membres inférieurs. J Econ Med. 1994;12:109–26.
Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996;5:539–54.
Lamping DL, Abenhaim LA, Kurz X, Schroter S, Kahn SR, and the VEINES Group. Measuring quality of life and symptoms in chronic venous disorders of the leg: development and psychometric evaluation of the VEINES-QOL/VEINES-SYM questionnaire. Qual Life Res. 1998;7(7):621–2. Abstract.
Ware JE Jr, Kosinki MA, Keller SD. SF-36 Physical and Mental Component Summary Measures: A User’s Manual. Boston, Mass: The Health Institute, New England Medical Center; 1994.
© Society of General Internal Medicine 2000